Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

1/31/2020 Database Update: API Import to Russia (November 2019)

Between January and November 2019, Russia imported 118 bln RUB worth of APIs (customs clearance prices, VAT included), which is in monetary terms (rubles) 35.6% higher than that of the same period in 2018. The dynamics in physical terms (tons) are +12.9%, with 12 thousand tons. Price rises are obviously the main growth factor here.

1/29/2020 Database Update: Import of Veterinary Drugs, Feed Supplements, and Veterinary APIs to Russia (November 2019)

Between January and November 2019, Russia imported 33.1 bln RUB worth of veterinary drugs (customs clearance prices, VAT included), which is surprisingly higher than the import of feed supplements (32.5 bln RUB). The reason lies both in the sudden growth of veterinary drug imports (+41.7% in rubles) and the significant drop in feed supplement imports (-7.7%). The import of veterinary APIs still has the highest dynamics among the veterinary product imports (+66.3% and 2.9 bln RUB).

1/28/2020 Database Update: Pharmaceutical Drug Import to Russia (November 2019)

Between January and November 2019, Russia imported 703.9 bln RUB worth of ready-made pharmaceutical drugs (customs clearance prices, VAT included), which is in monetary terms (rubles) 47.7% higher than that of the same period in 2018, and 116.3 bln RUB worth of in-bulk drugs, with the dynamics in monetary terms of +18.9%.

12/31/2019 Database Update: Pharmaceutical Drug Production in Russia (November 2019)

Between January and November 2019, Russia manufactured 383.9 bln RUB worth of pharmaceutical drugs (manufacturer’s prices, VAT included), which is in monetary terms (rubles) 25.8% higher than the production volume in 2018. In physical terms, the production volume is 4.1 bln units, or 67.2 bln minimum dosage units (MDU). The dynamics in physical terms are +6.5% in units and +5.3% in MDU.

12/30/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): Only 5% of Doctors Find Statistics by Ministry of Health on Average Salaries Believable

The vast majority of doctors (92%) consider the official statistics of the Ministry of Health and Rosstat on average salaries not reliable, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Around 37% of the respondents consider the official statistics to be completely unreliable, believing that the figures provided by Ministry of Health are “several times” higher than the real ones.

12/24/2019 Database Update: Pharmaceutical Drug Export from Russia (September 2019)

Between January and September 2019, Russia exported 32.5 bln RUB worth of pharmaceutical drugs (customs duties included), which is in monetary terms (rubles) 22.4% higher than that of the same in 2018. The two-digit growth rates have been registered since 2018 (the dynamics in 2018 were +16.1%). The dynamics in physical terms (units) are +6.7%, with 653 mln units.

12/18/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): Excessive Workloads and Healthcare System Failures Are Main Causes of Medical Errors

35% of doctors believe that the main cause of medical errors are “excessive workloads”, followed by “failures of the healthcare system”, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. However, excessive workloads are also a direct result of the improper organization of the healthcare system.

12/17/2019 Database Update: Veterinary Drug Retail Sales Audit in Russia (October 2019)

The Russia market of veterinary products consists of two main segments: households’ purchases and agricultural complexes and farms’ purchases. The volume of households’ purchases amounted to 18.1 bln RUB (retail prices, VAT included) in October 2019. Pet medicines account for 92% of the volume in monetary terms, while livestock medicines – for around 8%.

12/10/2019 Database Update: Pharmaceutical Drug Import for Clinical Trials to Russia (September 2019)

Between January and September 2019, Russia imported 532.3 thousand units, 13.1 bln RUB worth of pharmaceutical drugs for clinical trials (CT) (customs clearance prices, VAT included). The dynamics in physical terms (units) are only +0.4%. The dynamics in monetary terms (rubles) are much higher, +9.8%. The importers were most active in Q3 2019.

12/6/2019 Database Update: Pharmaceutical Drug Production in Russia (October 2019)

Between January and October 2019, Russia manufactured 341.3 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 23.6% higher than that of the same period in 2018. In physical terms, the dynamics are only +0.8% in units and +0.4% in minimum dosage units (MDU). The total production volume is 3.5 bln units and around 57.9 bln MDUs.